Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live from the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2011, at 10:20 a.m. ET. In addition, Alkermes’ corporate presentation will be webcast live from the UBS Global Life Sciences Conference on Wednesday, September 21, 2011, at 2:30 p.m. ET. Both presentations will be webcast from the Grand Hyatt Hotel in New York City. The presentations may be accessed at www.alkermes.com. The presentations will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients’ lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes’ robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.